302 related articles for article (PubMed ID: 14760786)
1. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.
Doran MF; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Feb; 31(2):207-13. PubMed ID: 14760786
[TBL] [Abstract][Full Text] [Related]
2. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study.
Karlson EW; Mandl LA; Hankinson SE; Grodstein F
Arthritis Rheum; 2004 Nov; 50(11):3458-67. PubMed ID: 15529351
[TBL] [Abstract][Full Text] [Related]
3. Does estrogen replacement therapy protect against rheumatoid arthritis?
Spector TD; Brennan P; Harris P; Studd JW; Silman AJ
J Rheumatol; 1991 Oct; 18(10):1473-6. PubMed ID: 1765970
[TBL] [Abstract][Full Text] [Related]
4. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis.
Pikwer M; Bergström U; Nilsson JA; Jacobsson L; Berglund G; Turesson C
Ann Rheum Dis; 2009 Apr; 68(4):526-30. PubMed ID: 18477739
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
6. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
7. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period.
Doran MF; Pond GR; Crowson CS; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Mar; 46(3):625-31. PubMed ID: 11920397
[TBL] [Abstract][Full Text] [Related]
10. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
11. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.
Gabriel SE; Crowson CS; O'Fallon WM
Arthritis Rheum; 1999 Mar; 42(3):415-20. PubMed ID: 10088762
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
14. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study.
Pedersen M; Jacobsen S; Klarlund M; Frisch M
J Rheumatol; 2006 Jun; 33(6):1069-74. PubMed ID: 16622905
[TBL] [Abstract][Full Text] [Related]
16. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.
Pedersen M; Jacobsen S; Klarlund M; Pedersen BV; Wiik A; Wohlfahrt J; Frisch M
Arthritis Res Ther; 2006; 8(4):R133. PubMed ID: 16872514
[TBL] [Abstract][Full Text] [Related]
17. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.
Sverdrup B; Källberg H; Bengtsson C; Lundberg I; Padyukov L; Alfredsson L; Klareskog L;
Arthritis Res Ther; 2005; 7(6):R1296-303. PubMed ID: 16277683
[TBL] [Abstract][Full Text] [Related]
18. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Sep; 46(9):2287-93. PubMed ID: 12355475
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample.
De Pablo P; Dietrich T; Karlson EW
Arthritis Rheum; 2007 Aug; 57(6):953-62. PubMed ID: 17665477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
